Chair

Nigel Titchener-Hooker
Professor, Biochemical Engineering
University College London
London, United Kingdom


Board Members

Stuart Builder
Strategic Biodevelopment
San Francisco, USA
(formerly Director, Strategic Development, Genentech, Inc.)

Jonathan Coffman
Associate Research Fellow
Pfizer, Inc.
Andover, USA

Charles Cooney
Professor, Chemical and Biochemical Engineering
Department of Chemical Engineering
Massachusetts Institute of Technology
Cambridge, USA

Steven Cramer
Professor, Isermann Department of Chemical Engineering
Rensselaer Polytechnic Institute
Troy, USA

John Curling
John Curling Consulting AB
Uppsala, Sweden
(formerly President, BioProcess Division, Pharmacia Biotech AB)

Stephen W. Drew
Consultant
Drew Solutions LLC
Summit, USA

Brian Kelley
Vice President, Bioprocess Development
Genentech, Inc.
South San Francisco, USA

Charles E. Glatz
Professor, Chemical and Biological Engineering
Iowa State University
Ames, USA

Sam Guhan
Amgen, Inc.
Thousand Oaks, USA

Dr. Maria-Regina Kula
Professor, Institute of Enzyme Technology
Heinrich-Heine University Düsseldorf
Jülich, Germany

Michael Ladisch
Distinguished Professor and Director
Laboratory of Renewable Resources Engineering
Purdue University
West Lafayette, USA

Ann Lee
Vice President, Process Development
Genentech, Inc.
South San Francisco, USA

Jill Myers
President
BioPro Consulting, Inc.
San Diego, USA

Todd Przybycien
Professor, Chemical Engineering and Biomedical Engineering
Carnegie Mellon University
Pittsburgh, USA

R. Andrew Ramelmeier
Vice President, Manufacturing, Process Development & Facilities
BioMarin Pharmaceutical
Novato, USA

Arne Staby
Scientific Director
Project Planning & Management
Novo Nordisk A/S Gentofte
Denmark

Kenneth G. Taksen
Consultant
Vice President Global Biologics, Pfizer, Inc. (Retired)
Lakewood Ranch, USA

Jörg Thömmes
Director, Purification Development
Biogen Idec
Cambridge, USA

Ad hoc member, ACS Division of Biochemical Technology Executive Committee representative:
Arin Bose
Director, Biologics, Bioprocess R & D, Pfizer Global Research and Development
Pfizer, Inc., USA

Recovery Series representative to the Executive Committee, ACS Division of Biochemical Technology:
Brian Kelley, Genentech, Inc., USA